The UNLV Nevada Institute of Personalized Medicine (NIPM) will be hosting the "Alzheimer’s Disease Therapeutic Pipeline" seminar this Friday, Feb. 17, at 4 p.m. as part of its ongoing seminar series. Cleveland Clinic Lou Ruvo Center for Brain Health's Dr. Jeffrey Cummings and Dr. Aaron Ritter will speak on the subject.
Dr. Cummings is the director of Cleveland Clinic Lou Ruvo Center for Brain Health in Las Vegas, Nevada, and Cleveland, Ohio. He is also the Camille and Larry Ruvo Chair of the Neurological Institute of Cleveland Clinic and professor of medicine (neurology) at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. Dr. Cummings is principal investigator/director of the NIH/NIGMS-funded Center for Neurodegeneration and Translational Neuroscience. He has authored or edited 40 books and published more than 700 peer-reviewed papers. Dr. Cummings is interested in clinical trials, developing new therapies for brain diseases, and the interface of neuroscience and society.
Dr. Ritter is associate staff, neuropsychiatry and behavioral neurology, as well as director of clinical trials at Cleveland Clinic Lou Ruvo Center for Brain Health. He treats adult neurological patients and leads the clinical research department by conducting urgently needed trials to advance the prevention, early detection, and treatment for Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, and Huntington’s disease. Dr. Ritter initially joined the Cleveland Clinic Lou Ruvo Center for Brain Health in July 2014 as a clinical fellow in behavioral neurology and neuropsychiatry. He comes to Las Vegas from Tucson following the completion of his internship in pediatrics and three-year residency in psychiatry at the University of Arizona.
When: Friday, Feb. 17, 4:00 p.m.
Where: Science and Engineering Building (SEB), Room 1242